Last reviewed · How we verify
NCT02826733: HEMISPHERENOR
Evaluation of the Implementation of the Hemispheric Dominance During Development
trial testing Electroencephalogram (EEG) in Neuroimaging in 120 participants. Status unknown.
3 November 2021
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 4 November 2009 |
| Primary completion | 3 November 2021 |
| Estimated completion | 3 November 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Electroencephalogram (EEG)
- Near Infra Red Spectroscopy (NIRS)
- magnetic resonance imaging (MRI)
Conditions studied
- Neuroimaging — all drugs for Neuroimaging →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
Adults 0 Days to 10 Weeks, any sex, with Neuroimaging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many cognitive functions in human are based on asymmetric brain networks. For most adults, language is processed largely by the left hemisphere while other auditory treatments, such as voice recognition are rather based on the right hemisphere. Many studies helped to highlight the presence of anatomical and functional asymmetries both in the first months of life. What are the causes of these imbalances? How do they develop? Are they necessary for operation or for effective learning? The investigators would like in this work, in collaboration with applied mathematics team of Compiègne and INSERM team, to determine from which period the development of hemispheric dominance is set up for recognition of language and in which brain structure it occurs in preterm infants whose sound environment is usually very different from that of the fetus. The impact of this environment on brain development of infants and their early learning will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02826733
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electroencephalogram (EEG)
Trials testing the same drug.
- NCT06999967 — Stanford-Lucidify EEG Delirium Study · not yet recruiting
- NCT06389721 — Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy · recruiting
- NCT05806697 — Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study · NA · recruiting
- NCT03040024 — Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients · Phase 4 · terminated
- NCT02292368 — Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia · NA · completed
Other recruiting trials for Neuroimaging
Currently open trials in the same condition.
- NCT05698511 — Neural and Physiological Correlates of Psychedelic Sub-states · Phase 1 · active not recruiting
- NCT04810858 — Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury · NA · recruiting
- NCT04951700 — Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia · active not recruiting
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02826733 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02826733.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing